Newsroom

PARIS--(BUSINESS WIRE)--  In line with its strategy to refocus its renewable development on large utility-scale solar and wind farms in order to benefit from economies of scale, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces that it has completed the divestment of all its distributed solar assets (around 170 MW), mainly rooftop installations, across 7 European countries (France, Belgium, the Netherlands, Spain, Portugal, the United Kingdom and Luxembourg) to Amarenco and AMPYR Distrib...

PARIS--(BUSINESS WIRE)--In line with its strategy to refocus its renewable development on large utility-scale solar and wind farms in order to benefit from economies of scale, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces that it has completed the divestment of all its distributed solar assets (around 170 MW), mainly rooftop installations, across 7 European countries (France, Belgium, the Netherlands, Spain, Portugal, the United Kingdom and Luxembourg) to Amarenco and AMPYR Distribut...

PARIS--(BUSINESS WIRE)--Conformément à sa stratégie de recentrage de son développement renouvelable sur les fermes solaires et éoliennes de grande taille pour tirer parti des effets d’échelle, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) annonce avoir finalisé la cession de l’ensemble de ses actifs solaires distribués (environ 170 MW) majoritairement sur toitures, dans 7 pays d’Europe (France, Belgique, Pays-Bas, Espagne, Portugal, Royaume-Uni, Luxembourg) à Amarenco et à AMPYR Distributed En...

LONDON--(BUSINESS WIRE)--  Commonwealth Bank of Australia Issue of USD 30,000,000.00 Floating Rate Notes due 15 January 2033 Series no 6657 Tranche 1 MTN ISSUE NAME. Our Ref. MS3157 ISIN Code. XS2977999593 TOTAL INTEREST AMT. CURRENCY CODE. USD DAY BASIS. 30/360 BOND BASIS (A001) NUM OF DAYS. 90 INTEREST RATE. 5.23446 PCT VALUE DATE. 15/07/2026 INTEREST PERIOD. 15/04/2026 TO 15/07/2026 USD 392,584.5 POOL FACTOR. N/A...

MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN : FR0010120402 ; Mnemo : ALTHE), société innovante développant Sonovein®, une plateforme robotique pour la thérapie non invasive des varices par ultrasons focalisés de haute intensité (HIFU), annonce que son Conseil d’Administration, réuni le 8 juillet 2026, a nommé Monsieur Vincent Gardès en qualité de Président du Conseil d’Administration, avec effet immédiat. Administrateur de Theraclion depuis l’Assemblée Générale du 18 ju...

LONDON--(BUSINESS WIRE)--  Santander UK PLC Issue of GBP 1,500,000,000.00 Floating Rate Covered Bonds due Jan 2028 Series 80 Tranche 1 MTN ISSUE NAME. Our Ref. MP2432 ISIN Code. XS2574480708 TOTAL INTEREST AMT. CURRENCY CODE. GBP DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 91 INTEREST RATE. 4.3976 PCT VALUE DATE. 13/07/2026 INTEREST PERIOD. 13/04/2026 TO 13/07/2026 GBP 16,445,819.18 POOL FACTOR. N/A...

MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused Ultrasound (HIFU), announces that its Board of Directors, which met on July 8, 2026, has appointed Mr. Vincent Gardès as Chairman of the Board of Directors, with immediate effect. A Director of Theraclion since the General Meeting of June 18, 2026, after having served...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares and Weekly Summary of Transactions in Own Shares – 8 July 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 8 July 2...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and partner AstraZeneca today announced that the CARDIO-TTRansform Phase 3 trial for eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy endpoint of the composite outcome of cardiovascular (CV) mortality and recurrent CV clinical events up to Week 140 compared with placebo. In this contemporary patient population treated with standard of care, includin...

LONDON--(BUSINESS WIRE)--  Commonwealth Bank of Australia Issue of EUR 255,000,000.00 Floating Rate Notes due October 2026 Series No 6700 Tranche 1 MTN ISSUE NAME. Our Ref. MU6527 ISIN Code. XS3206613666 TOTAL INTEREST AMT. CURRENCY CODE. EUR DAY BASIS. Actual/360 (A004) NUM OF DAYS. 91 INTEREST RATE. 2.25382 PCT VALUE DATE. 15/07/2026 INTEREST PERIOD. 15/04/2026 TO 15/07/2026 EUR 1,452,774.81 POOL FACTOR. N/A...